McClellan To Head Medicare Rx Law Implementation: Will Greater FDA/CMS Cooperation Ensue?
This article was originally published in The Pink Sheet Daily
Executive Summary
President Bush nominates FDA Commissioner McClellan to head Centers for Medicare & Medicaid Services Feb. 20. McClellan's closest advisors will remain at FDA, suggesting era of greater cooperation between the two agencies could result.
You may also be interested in...
FDA/CMS Formal Collaboration Will Include Data Sharing, Parallel Review
A draft memorandum of understanding is under review at both agencies, Centers for Medicare & Medicaid Services Chief Medical Officer Sean Tunis, MD, told the BIO annual meeting in San Francisco. The MOU will address parallel review for new technologies, and allow the agencies to share scientific expertise and data.
FDA/CMS Formal Collaboration Will Include Data Sharing, Parallel Review
A draft memorandum of understanding is under review at both agencies, Centers for Medicare & Medicaid Services Chief Medical Officer Sean Tunis, MD, told the BIO annual meeting in San Francisco. The MOU will address parallel review for new technologies, and allow the agencies to share scientific expertise and data.
Energy & Commerce Committee Closely Monitors First Post-McClellan ODAC Meeting
Rep. Deutsch and Energy & Commerce Committee staffers get first row reserved seat at May 3 Genta’s Genasense and Allos’ Excelar meeting. Meeting serves as the litmus test for concerns that agency review process will “revert” to overregulation by FDA in post-Commissioner McClellan period.